𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bioequivalence evaluation of lomefloxacin 400 mg tablets (Lomax® Versus Maxaquin®) in healthy human volunteers

✍ Scribed by Khalid A. Al-Rashood; Khalil I. Al-Khamis; Yoursy M. El-Sayed; Sulaiman Al-Bella; Mohd A. Al-Yamani; S. Mahmood Alam; Ruwayda Dham

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
116 KB
Volume
20
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bioequivalence evaluation of norfloxacin
Bioequivalence evaluation of norfloxacin 400 mg tablets (Uroxin® and Noroxin®) in healthy human volunteers
✍ Khalid A. Al-rashood; Khalil I. Al-khamis; Yoursy M. El-sayed; Sulaiman Al-bella 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

A bioequivalence study of two oral formulations of 400 mg norfloxacin was carried out in 18 healthy volunteers according to a single dose, two-sequence, cross-over randomized design at College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, jointly with King Khalid University Hospital. The

Bioequivalence evaluation of two brands
Bioequivalence evaluation of two brands of gliclazide 80 mg tablets (Glyzide® & Diamicron®) — in healthy human volunteers
✍ Naji Najib; Nasir Idkaidek; M. Beshtawi; Mohammed Bader; Isra' Admour; S. Mahmoo 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

A randomized, two-way, crossover, bioequivalence study in 24 fasting, healthy, male volunteers was conducted to compare two brands of gliclazide 80 mg tablets, Glyzide (Julphar, UAE) as test and Diamicron (Servier Industries, France) as reference product. The study was performed at the International